US Patent No. 9,359,289

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
Jun 09, 2016

Intrexon has been awarded US Patent No. 9,359,289, "Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex."